Investment Analysts’ Weekly Ratings Changes for Oscar Health (OSCR)

Oscar Health (NYSE: OSCR) recently received a number of ratings updates from brokerages and research firms:

• 10/14/2025 – Oscar Health is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $17.00 price target on the stock.
• 10/8/2025 – Oscar Health had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 10/7/2025 – Oscar Health had its price target raised by analysts at Wells Fargo & Company from $10.00 to $14.00. They now have an “underweight” rating on the stock.
• 9/27/2025 – Oscar Health had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.

Insider Activity at Oscar Health

In other Oscar Health news, insider Mario Schlosser sold 395,000 shares of the business’s stock in a transaction dated Monday, September 22nd. The stock was sold at an average price of $18.43, for a total value of $7,279,850.00. Following the completion of the transaction, the insider directly owned 501,148 shares of the company’s stock, valued at approximately $9,236,157.64. The trade was a 44.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 25.11% of the stock is currently owned by company insiders.

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.